HER2‐positive breast cancer, recurrent breast cancer, stage IIA breast cancer, stage IIB breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer, stage IV breast cancer, breast adenocarcinoma, inflammatory breast carcinoma. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.